FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $637,000 | +422.1% | 10,885 | +427.1% | 0.14% | +264.9% |
| Q3 2021 | $122,000 | -85.6% | 2,065 | -78.9% | 0.04% | -84.8% |
| Q2 2021 | $850,000 | +51.8% | 9,792 | +44.2% | 0.24% | +28.4% |
| Q1 2021 | $560,000 | -16.3% | 6,792 | -7.6% | 0.19% | -12.0% |
| Q4 2020 | $669,000 | -46.6% | 7,352 | -76.5% | 0.22% | -43.2% |
| Q3 2020 | $1,252,000 | +51.4% | 31,317 | +30.0% | 0.38% | +61.7% |
| Q2 2020 | $827,000 | – | 24,092 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
| Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
| Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
| Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
| DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
| Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
| Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
| Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
| Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |